The Biomarkers and Imaging Discovery and Development Committee (BIDD) reviews, funds and manages research in all types of biomarkers (predisposition, screening, diagnostic, prognostic, predictive, pharmacological and surrogate response) using invasive (i.e., surgical specimens or biofluids) and non-invasive (i.e., imaging) technologies.
The remit of BIDD covers the following areas:
- Biomarker discovery projects using human samples;
- Biomarker assay development projects;
- Biomarker qualification projects;
- Imaging discovery and evaluation projects.
BIDD works with the Clinical and Translational Research Committee (CTRC), the Clinical Trials Advisory and Awards Committee (CTAAC), the Discovery Committee (DC), the Biological Sciences Committee (BSC), the Scientific Executive Board (SEB) and other Cancer Research UK funding committees to ensure co-ordination of activities.
It also advises the SEB and CTRC on opportunities for promoting and improving the quality of biomarker and imaging research.
Available scheme
The Biomarkers and Imaging Discovery and Development Committee (BIDD) currently offers the following scheme:
Committee secretariat
Email: Maria Lioumi
Other details
Committee Members
View members of BIDD...
Terms of Reference
View the Terms of Reference for BIDD...
